Gynaecological cancers (cervical, ovarian and uterine) - research funded

Cervical cancer

Cervical cancer occurs when abnormal cells in the cervix turn into cancer cells. The cancer cells break through the surface cells (epithelium) and into the underlying tissue (stroma) of the cervix.

At diagnosis, the cancer is often just within the cervix, but it may spread to tissues around the cervix (e.g. the vagina) or to other parts of the body.

Incidence

In Victoria, about 213 women are diagnosed with the disease every year.

Ovarian cancer

Ovarian cancer is a malignant tumour in one or both ovaries. Some cases of ovarian cancer may form in the fallopian tube and spread to the ovary.

Incidence
Each year, about 360 Victorian women are diagnosed with ovarian cancer. It's the ninth most common cancer in women.

Uterine cancer

Cancer that begins from abnormal cells in the lining of the uterus (the endometrium) or the muscle tissue (myometrium).

Incidence

About 645 women in Victoria are diagnosed with uterine cancer each year.

Research funded

$6,972,673 million has been given to fund research specifically into gynaecological cancers.

In addition, more than $16.2 million has been spent on research projects looking into the detection and treatment of all tumour types (including gynaecological).

Overall, Cancer Council Victoria has funded $69 million worth of lab-based research in Victorian hospitals, universities and research institutions since 2003.

More on external research funded per tumour type.